We are live on ! Find out more
DMAQR

Deep Medicine Acquisition Corp. Rights
DMAQR

Delisted

DMAQR was delisted on the 31st of January, 2024.

Back to rankings

31 hedge funds and large institutions have $1.1M invested in Deep Medicine Acquisition Corp. Rights in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

11% more funds holding

Funds holding: 28 → 31 (+3)

36% less capital invested

Capital invested by funds: $1.73M → $1.1M (-$630K)

Holders
31
Holders Change
+3
Holders Change %
+10.71%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
3
Closed
1
Calls
$333K
Puts
–
Net Calls
+$333K
Net Calls Change
-$1K

Top Buyers

Rank Fund Capital Flow
1
HIM
HGC Investment Management
Ontario, Canada
+$48.8K
2
CAC
Cowen and Company
New York
+$14.8K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$7.09K
4
MC
Meteora Capital
Florida
+$4.65K
5
PL
Parkwood LLC
Ohio
+$4.13K

Top Sellers

Rank Fund Capital Flow
1
WAM
Wolverine Asset Management
Illinois
-$11.4K
2
MF
Magnetar Financial
Illinois
-$7.8K
3
VF
Virtu Financial
New York
-$3.09K
4
TRCT
Tower Research Capital (TRC)
New York
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAC
1
Cowen and Company
New York
$192K +$14.8K +90,700 +5%
MP
2
Mangrove Partners
Connecticut
$165K – – –
HIM
3
HGC Investment Management
Ontario, Canada
$88K +$48.8K +300,000 +100%
OCAM
4
Owl Creek Asset Management
New York
$83K – – –
YCM
5
Yakira Capital Management
Connecticut
$83K – – –
Hudson Bay Capital Management
6
Hudson Bay Capital Management
Connecticut
$66K – – –
SCM
7
Shaolin Capital Management
Florida
$56K – – –
KPF
8
K2 Principal Fund
Ontario, Canada
$52K – – –
AA
9
AQR Arbitrage
Connecticut
$41K – – –
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$33K – – –
WAM
11
Wolverine Asset Management
Illinois
$30K -$11.4K -69,800 -20%
WA
12
Whitebox Advisors
Minnesota
$28K – – –
PC
13
Periscope Capital
Ontario, Canada
$27K – – –
SCM
14
Saba Capital Management
New York
$26K – – –
CH
15
CVI Holdings
Delaware
$25K – – –
MTCM
16
Mint Tower Capital Management
Netherlands
$21K – – –
RCM
17
Rivernorth Capital Management
Florida
$17K – – –
Walleye Capital
18
Walleye Capital
New York
$16K +$10 +64 +0%
SIA
19
SkyView Investment Advisors
New Jersey
$11K – – –
Walleye Trading
20
Walleye Trading
New York
$9K +$6 +36 +0%
TCM
21
Tuttle Capital Management
Connecticut
$8K – – –
HF
22
HRT Financial
New York
$5K – – –
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
$5K +$7.09K +43,550 New
FLC
24
Fifth Lane Capital
Texas
$3K – – –
PL
25
Parkwood LLC
Ohio
$3K +$4.13K +25,400 New
1
2

DMAQR Hedge Fund Activity: Q2 2022 in Review

31 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Deep Medicine Acquisition Corp. Rights (DMAQR) for Q2 2022, worth a combined $1.1M — down 36% from $1.73M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new DMAQR positions and 1 closed out — a net gain of 3 holders — while 4 added to existing stakes and 3 trimmed.

The largest buyer was HGC Investment Management, adding an estimated $48.8K. The largest seller was Wolverine Asset Management, cutting an estimated $11.4K.

  • 31 institutional investors held Deep Medicine Acquisition Corp. Rights (DMAQR) as of Q2 2022, up from 28 in Q1 2022.
  • Funds reported $1.1M of Deep Medicine Acquisition Corp. Rights stock for Q2 2022, down 36% quarter-over-quarter.
  • 4 funds opened new Deep Medicine Acquisition Corp. Rights positions in Q2 2022 and 1 closed out, a net change of +3 holders.
  • The largest Deep Medicine Acquisition Corp. Rights buyer in Q2 2022 was HGC Investment Management, an estimated $48.8K added.
  • The largest Deep Medicine Acquisition Corp. Rights seller in Q2 2022 was Wolverine Asset Management, an estimated $11.4K sold.

Based on aggregated 13F filings for Q2 2022.